Dong‐Seok Yim

1.7k total citations
112 papers, 1.3k citations indexed

About

Dong‐Seok Yim is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Dong‐Seok Yim has authored 112 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Pharmacology and 17 papers in Molecular Biology. Recurrent topics in Dong‐Seok Yim's work include Pharmacogenetics and Drug Metabolism (17 papers), Statistical Methods in Clinical Trials (16 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). Dong‐Seok Yim is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Statistical Methods in Clinical Trials (16 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). Dong‐Seok Yim collaborates with scholars based in South Korea, United States and Ethiopia. Dong‐Seok Yim's co-authors include Seunghoon Han, Jong-Tae Lee, Soo Hyeon Bae, Dong‐Gun Lee, Su‐Mi Choi, Howard Lee, Carl C. Peck, Honghui Zhou, Jin‐Hong Yoo and Si‐Hyun Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Dong‐Seok Yim

109 papers receiving 1.3k citations

Peers

Dong‐Seok Yim
DR Mould United States
MO Karlsson Sweden
Kevin Sweeney United States
Yoh Takekuma Japan
Nidal Al‐Huniti United States
Young‐A Heo New Zealand
Wen Chyi Shyu United States
Nathalie Bleyzac France
Yoshitaka Yano Japan
Nitin Mehrotra United States
DR Mould United States
Dong‐Seok Yim
Citations per year, relative to Dong‐Seok Yim Dong‐Seok Yim (= 1×) peers DR Mould

Countries citing papers authored by Dong‐Seok Yim

Since Specialization
Citations

This map shows the geographic impact of Dong‐Seok Yim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Seok Yim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Seok Yim more than expected).

Fields of papers citing papers by Dong‐Seok Yim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Seok Yim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Seok Yim. The network helps show where Dong‐Seok Yim may publish in the future.

Co-authorship network of co-authors of Dong‐Seok Yim

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Seok Yim. A scholar is included among the top collaborators of Dong‐Seok Yim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Seok Yim. Dong‐Seok Yim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yim, Dong‐Seok, et al.. (2022). Prediction of metabolizing enzyme-mediated clinical drug interactions using in vitro information. Translational and Clinical Pharmacology. 30(1). 1–1. 4 indexed citations
2.
Han, Sungpil, Seunghoon Han, Ki‐Suk Kim, Hyang‐Ae Lee, & Dong‐Seok Yim. (2019). Usefulness of Bnet, a Simple Linear Metric in Discerning Torsades De Pointes Risks in 28 CiPA Drugs. Frontiers in Pharmacology. 10. 1419–1419. 7 indexed citations
3.
Polasek, Thomas M., Amin Rostami‐Hodjegan, Dong‐Seok Yim, et al.. (2019). What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing. The AAPS Journal. 21(2). 17–17. 24 indexed citations
4.
Bae, Soo Hyeon, et al.. (2018). Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans. Korean Journal of Physiology and Pharmacology. 22(3). 321–321. 6 indexed citations
5.
6.
Costantini, Marco, et al.. (2015). SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN.. PubMed. 46(4). 743–52. 1 indexed citations
7.
Yim, Dong‐Seok, Seunghoon Han, Jong-Tae Lee, et al.. (2015). Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects. Drug Design Development and Therapy. 9. 1233–1233. 11 indexed citations
8.
Kim, Seok Jin, Hye Jin Kang, Jin Seok Kim, et al.. (2013). A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas. Investigational New Drugs. 31(6). 1514–1521. 9 indexed citations
9.
10.
Wu, Jerry, R. Michael Baldwin, Magnus Ingelman‐Sundberg, et al.. (2011). Omeprazole limited sampling strategies to predict area under the concentration–time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping. European Journal of Clinical Pharmacology. 68(4). 407–413. 4 indexed citations
11.
Hwang, Yang‐Ha, Wonku Kang, Sook Jin Seong, et al.. (2011). Population Pharmacokinetic/Pharmacodynamic Modeling of Clopidogrel in Korean Healthy Volunteers and Stroke Patients. The Journal of Clinical Pharmacology. 52(7). 985–995. 10 indexed citations
12.
Kim, Jong‐Hyun, et al.. (2008). Population pharmacokinetics of arbekacin in burn patients. European Journal of Clinical Pharmacology. 64(6). 599–603. 3 indexed citations
13.
Lee, Dong‐Gun, Hochang Chae, Dong‐Seok Yim, et al.. (2008). Population pharmacokinetics of intravenous itraconazole in patients with persistent neutropenic fever. Journal of Clinical Pharmacy and Therapeutics. 34(3). 337–344. 8 indexed citations
14.
Kim, Seong-Yun, et al.. (2006). NMDA receptor-dependent inhibition of synaptic transmission by acute ethanol treatment in rat corticostriatal slices. Korean Journal of Physiology and Pharmacology. 10(6). 303–307. 1 indexed citations
15.
Lee, Howard, Dong‐Seok Yim, Honghui Zhou, & Carl C. Peck. (2005). Evidence of effectiveness: How much can we extrapolate from existing studies?. The AAPS Journal. 7(2). E467–E474. 14 indexed citations
16.
Lee, Dong‐Gun, Dong‐Seok Yim, Su‐Mi Choi, et al.. (2004). Efficacies of Teicoplanin in Patients with Febrile Neutropenia. Infection and Chemotherapy. 36(2). 83–91. 2 indexed citations
17.
Yim, Dong‐Seok, et al.. (2002). Population pharmacokinetics of intravenous valproic acid in Korean patients. Journal of Clinical Pharmacy and Therapeutics. 27(6). 419–425. 32 indexed citations
18.
Yim, Dong‐Seok, Sue K. Park, Keun-Young Yoo, et al.. (2001). Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics. 11(4). 279–286. 89 indexed citations
19.
Shin, S. G., et al.. (1996). Erythrocyte thiopurine methyltransferase activity in a Korean population. British Journal of Clinical Pharmacology. 42(5). 638–641. 19 indexed citations
20.
Yim, Dong‐Seok, et al.. (1991). A Case of Herpes Esophagitis Confirmed by Electron Microscopic Findings.. Korean Journal of Gastrointestinal Endoscopy. 11(1). 73–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DR Mould Breakdown of academic impact, for papers by MO Karlsson Breakdown of academic impact, for papers by Kevin Sweeney Breakdown of academic impact, for papers by Yoh Takekuma Breakdown of academic impact, for papers by Nidal Al‐Huniti Breakdown of academic impact, for papers by Young‐A Heo Breakdown of academic impact, for papers by Wen Chyi Shyu Breakdown of academic impact, for papers by Nathalie Bleyzac Breakdown of academic impact, for papers by Yoshitaka Yano Breakdown of academic impact, for papers by Nitin Mehrotra
Rankless by CCL
2026